Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ghita Benabdallah"'
Autor:
Loubna Alj, Asmae Khattabi, Raja Benkirane, Alem Zekaria, Ghita Benabdallah, Rachida Soulaymani Bencheikh, Amina Tebaa
Publikováno v:
European Journal of Clinical Pharmacology. 77:1235-1246
The study aimed to describe the epidemiological profile of medication errors (MEs) reported to the Moroccan Pharmacovigilance Center (MPVC), to determine factors associated with serious MEs, and to describe signals related to them. We carried out a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1686866c385f9349143f70e4710c222
https://doi.org/10.1007/s00228-021-03109-w
https://doi.org/10.1007/s00228-021-03109-w
Publikováno v:
E3S Web of Conferences, Vol 319, p 02025 (2021)
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use of hydroxychloroquine or chloroquine in combination with azythromycin as first-line treatment for all COVID-19 patients. The aim of this study is to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7342cd1be36b1a3a0e40eccac216b343
https://www.e3s-conferences.org/articles/e3sconf/pdf/2021/95/e3sconf_vigisan_02025.pdf
https://www.e3s-conferences.org/articles/e3sconf/pdf/2021/95/e3sconf_vigisan_02025.pdf
Autor:
Rachida Soulaymani-Bencheikh, Raja Benkirane, Shanti N. Pal, Loubna Alj, Houda Sefiani, Khedidja Hedna, L. Ouammi, Asmae Khattabi, Sten Olsson, Ghita Benabdallah
Publikováno v:
Drug Safety. 38:383-393
Pharmacovigilance centres (PVCs) in the World Health Organization (WHO) Programme for International Drug Monitoring have demonstrated their ability to detect preventable adverse drug reactions (ADRs) in their databases. In this field, there is no gol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c7f90a541e2e0188553b9bce2a740b
https://doi.org/10.1007/s40264-014-0257-5
https://doi.org/10.1007/s40264-014-0257-5
Publikováno v:
British Journal of Clinical Pharmacology. 67:687-690
1. Detecting medication errors needs collaboration between various organizations, such as patient safety institutions, pharmacovigilance centres, and poison control centres. In order to evaluate the input of pharmacovigilance centres and poison contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9406b31d1206bc606d24f59976ce5c27
https://doi.org/10.1111/j.1365-2125.2009.03426.x
https://doi.org/10.1111/j.1365-2125.2009.03426.x
Autor:
Asmae Khattabi, Raja Benkirane, Rachida Soulaymani Bencheikh, I. Ralph Edwards, Ghita Benabdallah
Publikováno v:
The International journal of risksafety in medicine. 23(1)
OBJECTIVES This study assesses the ability of Pharmacovigilance Centres (PVCs) to detect medication errors (ME) and to proceed to building Patient Safety (PS) via their information networks and to underline the limits for this challenge. METHODS This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::378ceb8f5767bec32317115e8b18013a
https://pubmed.ncbi.nlm.nih.gov/21507783
https://pubmed.ncbi.nlm.nih.gov/21507783